A clinical case of complications associated with acute myeloid leukemia
Keywords:
LEUKEMIA, MYELOID, ACUTE/ Complications, LYMPHOCYTE, THROMBOCYTOPENIA HOCYTE, THROMBOCYTOPENIAAbstract
Introduction: acute myeloid leukemia has a lower incidence in pediatric ages compared to lymphoblastic, which are classified into seven varieties. Although not the most frequent in childhood as it happens in adult stage, it is the one of larger cases of deaths registered, given by the biological characteristics of the disease, associated with a greater number of complications such as bacterial, viral, mycotic infections, as well as bleeding due to thrombocytopenia and coagulopathies.
Case report: a 16-year-old boy with a diagnosis of acute myeloid leukemia who after receiving intensive chemotherapy, relapses from his hematologic disease during the maintenance of treatment and dies as a result of intracranial hemorrhage, pseudomona and staphylococcus aureus infection.
Conclusion: persistence of neutropenia with exacerbation of infections despite the use of first-line antimicrobial therapy and prolongation of thrombocytopenia linked to loss of integrity of the vascular bed with hemorrhage in lethal sites of the central nervous system that with support of blood products tend to make refractoriness and influence on the mortality rate of these patients.
Downloads
References
1. Pérez-Saldivar ML, Fajardo-Gutiérrez A, Bernáldez-Ríos R, et al. Childhoodacuteleukemias are frequent in Mexico City: descriptive epidemiology. BMC Cancer. 2011; [citado 2016 enero 10]. 11: 355. https://www.ncbi.nlm.nih.gov/pubmed/21846410
2. Villalba Toquica CP, Martínez Silva PA, Acero H. caracterización clínico epidemiológica de los pacientes pediátricos con leucemias agudas en la clínica universitaria de Colombia. Serie de casos 2011-2014. Pediatr 2016; [citado 2016 enero10].49(1):[Aprox.5p.] http://www.sciencedirect.com/science/article/pii/S0120491216000148
3. Grove CS, Vassiliou GS. Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer Dis Model Mech. 2014; [citado 2016 enero 10]. 7: [Aprox.10p.]. https://www.ncbi.nlm.nih.gov/pubmed/25056697
4. Lassaletta AtienzaA. Leucemias. Leucemia linfoblásticaaguda. Pediatr Integral 2016; [citado 2016 enero 10]. XX (6): [Aprox.9p.]. https://www.pediatriaintegral.es/publicacion-2016-07/leucemias-leucemia-linfoblastica-aguda-2016-07/
5. Puumala SE, Ross JA, Aplenc R, Spector LG. Epidemiology of childhood acute myeloid leukemia.Pediatr Blood Cancer.2013; [citado 2016 enero 10]. 60: [Aprox.6p.]. http://onlinelibrary.wiley.com/doi/10.1002/pbc.24464/full
6. Molgaard-Hansen L, Möttönen M, Glosli H, Jónmundsson GK, Abrahamsson J, Hasle H; Nordic Society of PaediatricHaematology and Oncology (NOPHO). Treatment-related deaths in second complete remission in childhood acute myeloid leukaemia.Br J Haematol 2011; [citado 2016 enero 10]. 152: [Aprox.7p.]. https://www.ncbi.nlm.nih.gov/pubmed/21241281
7. Rivas Llamas JR. neutropenia febril: el punto de vista del hematólogo. Gaceta Mexicana de Oncología.2016; [citado 2016 enero 10]. 15(4): [Aprox.9p.]. http://www.elsevier.es/es-revista-gaceta-mexicana-oncologia-305-articulo-neutropenia-febril-el-punto-vista-S1665920116300517
8. Estey EH. Acute myeloid leukemia: 2014 update on risk-stratification and management. Am J Hematol 2014; [citado 2016 enero 10]. 89: [Aprox.14p.]. https://www.ncbi.nlm.nih.gov/pubmed/25318680
9. Online NCCN Guidelines Myeloid Growth Factors, version 1,2015 [citado 2016 enero 10]. Disponible en: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
10. Peña JA, Pantoja JA, Acosta AM, Argotty E, Mafla AC. Complicaciones asociadas y análisis de supervivencia de niños con leucemias agudas tratados con el protocolo BFM-95. Rev Univ. salud. 2014; [citado 2016 enero 10]. 16(1): [Aprox.12p.]. http://www.scielo.org.co/scielo.php?pid=S0124-71072014000100002&script=sci_abstract&tlng=es
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
